Skip to main content
. Author manuscript; available in PMC: 2019 Jun 17.
Published in final edited form as: Biol Blood Marrow Transplant. 2017 Nov 8;24(2):359–365. doi: 10.1016/j.bbmt.2017.10.040

Table 2.

Day 100 Chimerism

CD3 N=31*
100% CBU 17
CBU >80% 4
CBU <80% + Haplo 2
CBU <80% + Host 1
CBU <80% + Haplo + Host 4
Haplo 100% 1+
Host 100% 1++
CD33 N= 20**
100% CBU 6
CBU >90% 3
CBU <90% + haplo 6
CBU<90%+ haplo + host 3
Haplo 100% 2+
Host 100% 1++
*

32 patients alive and in remission on day 100 – data available on 31

**

Data only for WCMC patients ‒20 alive and in remission on day 100

+

one patient with failure of sustained engraftment of CBU unit and one patient with myeloid CBU engraftment, but no T-lymphoid engraftment.

++

one patient with autologous count recovery.